Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer
Clinical trial NCT02933944 · TERMINATED
Trial details
- NCT number
- NCT02933944
- Sponsor
- Targovax ASA
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2019-02-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.